(2R,3S)-Fmoc-3-cyclopentyl-Ser(TBS)-OH

Product#: FNK-CBB010
$523.25
Availability:
Ships in 1-2 Weeks

(2R,3S)-Fmoc-3-cyclopentyl-Ser(TBS)-OH





Cat. No: FNK-CBB010


Description
  • Molecular Formula : C29H39NO5Si,
  • M.W.:509.72,
  • Purity : >95% (HPLC),
  • Optical purity : >95% ee,
  • Optical activity Fmoc-β-hydroxy-α-amino acid (Serine) derivative.

size: 200mg

Storage Condition: -20℃, Dark Storage, Keep Dry
 

Optically Active Fmoc-Protected β-Hydroxy-α-amino Acid (Serine) Derivatives

Chiral Building Blocks for Peptide Synthesis and Drug Discovery Research


Optically active Fmoc-protected β-hydroxy-α-amino acid derivatives are highly valuable chiral building blocks for peptide and medium-sized molecule drug discovery. β-Hydroxy-α-amino acid residues are key structural motifs found in numerous peptide natural products and peptide-based therapeutics, including vancomycin. Leveraging proprietary technology developed by the Institute of Microbial Chemistry (BIKAKEN), we have successfully commercialized a unique series of non-natural serine derivatives possessing two contiguous stereogenic centers—compounds that have previously been difficult to obtain.

* Please do not hesitate to contact Diagnocine Technical support team, if you need a Structure Data Format (SDF) file and/or bulk purchase (large quantity) of the compounds.
* This product is for research use only.


FNK-718195-1_Diagnocine.jpg
The chiral building blocks are developed and supplied by proprietary technologies
from Institute of Microbial Chemistry (Bikaken).

 

Key Features

  • Ready for Direct Use in Solid-Phase Peptide Synthesis (SPPS):
    These N-Fmoc-protected amino acid derivatives, the most widely used protecting group strategy for SPPS, are supplied with the side-chain hydroxyl group also protected, enabling their direct use in peptide synthesis and in the preparation of amino acid analogues and derivatives.
     
  • High-Quality Chiral Reagents:
    All products meet stringent quality standards with chemical purity >95% and optical purity >95% ee, making them reliable chiral building blocks for synthetic applications.
     
  • A Unique Product Line Enabled by Proprietary Catalytic Technology:
    Utilizing the highly stereoselective direct catalytic asymmetric aldol reaction1 developed by the Institute of Microbial Chemistry (BIKAKEN), we have established a stable supply of diverse non-natural amino acid derivatives with a wide variety of side-chain structures. These products are ideal for expanding peptide drug discovery libraries and for the exploration of novel amino acid derivatives.
 

Product Table

All the compounds below are, Purity: >95% (HPLC), Optical Purity: >95% ee.
Click the compound name to view detailed information, click the product code to view the price list,
and click the chemical structure to enlarge the image.

 
Product Name Product code Structure Molecular Formula Molecular Weight CAS No. view page
(Size: 200 mg)
(2R,3S)-Fmoc-3-cyclobutyl-Ser(TBS)-OH FNK-CBB012 73518-IMC-CBB012-Structure-popup.jpg C28H37NO5Si 495.69 / Go_Button_Green_w40xh30-Diagnocine.png
(2S,3R)-Fmoc-3-cyclobutyl-Ser(TBS)-OH FNK-CBB011 73518-IMC-CBB011-Structure-popup.jpg C28H37NO5Si 495.69 / Go_Button_Green_w40xh30-Diagnocine.png
(2R,3S)-Fmoc-3-cyclohexyl-Ser(TBS)-OH FNK-CBB006 73518-IMC-CBB006-Structure-popup.jpg C30H41NO5Si 523.75 / Go_Button_Green_w40xh30-Diagnocine.png
(2S,3R)-Fmoc-3-cyclohexyl-Ser(TBS)-OH FNK-CBB005 73518-IMC-CBB005-Structure-popup.jpg C30H41NO5Si 523.75 / Go_Button_Green_w40xh30-Diagnocine.png
(2R,3S)-Fmoc-3-cyclopentyl-Ser(TBS)-OH FNK-CBB010 73518-IMC-CBB010-Structure-popup.jpg C29H39NO5Si 509.72 / current page
(2S,3R)-Fmoc-3-cyclopentyl-Ser(TBS)-OH FNK-CBB009 3518-IMC-CBB009-Structure-popup.jpg C29H39NO5Si 509.72 / Go_Button_Green_w40xh30-Diagnocine.png
(2R,3S)-Fmoc-3-cyclopropyl-Ser(TBS)-OH FNK-CBB004 73518-IMC-CBB004-Structure-popup.jpg C27H35NO5Si 481.66 / Go_Button_Green_w40xh30-Diagnocine.png
(2S,3R)-Fmoc-3-cyclopropyl-Ser(TBS)-OH FNK-CBB003 73518-IMC-CBB003-Structure-popup.jpg C27H35NO5Si 481.66 / Go_Button_Green_w40xh30-Diagnocine.png
(2R,3S)-Fmoc-3-ethyl-Ser(TBS)-OH FNK-CBB016 73518-IMC-CBB016-Structure-popup.jpg C26H35NO5Si 469.65 / Go_Button_Green_w40xh30-Diagnocine.png
(2S,3R)-Fmoc-3-ethyl-Ser(TBS)-OH FNK-CBB015 73518-IMC-CBB015-Structure-popup.jpg C26H35NO5Si 469.65 2382557-25-5 Go_Button_Green_w40xh30-Diagnocine.png
(2R,3S)-Fmoc-3-(1-ethylpropyl)-Ser(TBS)-OH FNK-CBB002 73518-IMC-CBB002-Structure-popup.jpg C29H41NO5Si 511.73 / Go_Button_Green_w40xh30-Diagnocine.png
(2S,3R)-Fmoc-3-(1-ethylpropyl)-Ser(TBS)-OH FNK-CBB001 C29H41NO5Si 511.73 / Go_Button_Green_w40xh30-Diagnocine.png
(2R,3S)-Fmoc-3-(1-methylethyl)-Ser(TBS)-OH FNK-CBB008 73518-IMC-CBB008-Structure-popup.jpg C27H37NO5Si 483.68 1447759-04-7 Go_Button_Green_w40xh30-Diagnocine.png
(2S,3R)-Fmoc-3-(1-methylethyl)-Ser(TBS)-OH FNK-CBB007 73518-IMC-CBB007-Structure-popup.jpg C27H37NO5Si 483.68 1379595-58-0 Go_Button_Green_w40xh30-Diagnocine.png
(2R,3S)-Fmoc-3-pentyl-Ser(TBS)-OH FNK-CBB020 73518-IMC-CBB020-Structure-popup.jpg C29H41NO5Si 511.73 / Go_Button_Green_w40xh30-Diagnocine.png
(2S,3R)-Fmoc-3-pentyl-Ser(TBS)-OH FNK-CBB019 73518-IMC-CBB019-Structure-popup.jpg C29H41NO5Si 511.73 / Go_Button_Green_w40xh30-Diagnocine.png
(2S,3R)-Fmoc-3-propyl-Ser(TBS)-OH FNK-CBB017 73518-IMC-CBB017-Structure-popup.jpg C27H37NO5Si 483.68 / Go_Button_Green_w40xh30-Diagnocine.png
(2R,3S)-Fmoc-3-(tetrahydropyran-4-yl)-Ser(TBS)-OH FNK-CBB014 73518-IMC-CBB014-Structure-popup.jpg C29H39NO6Si 525.72 / Go_Button_Green_w40xh30-Diagnocine.png
(2S,3R)-Fmoc-3-(tetrahydropyran-4-yl)-Ser(TBS)-OH FNK-CBB013 73518-IMC-CBB013-Structure-popup.jpg C29H39NO6Si 525.72 / Go_Button_Green_w40xh30-Diagnocine.png
 

Reference

  1. Takeuchi, T. and Shibasaki, M., Org. Lett., 26(37), 7981(2024). [PMID:39255778]

 

Satisfaction
Quality Rating
Value Rating
Style Rating
X